Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunosuppression-reverting oligonucleotides inhibiting the expression of CD39

Immunosuppression-reverting oligonucleotides inhibiting the expression of CD39

US Patent 11959083 · Granted Apr 16, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism2024
Oligonucleotide inhibiting the expression of Chop2023
ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism2023
Antisense oligonucleotides for inhibition of PD-L1 expression and treating cance2023
Antisense oligonucleotides for inhibition of PD-L1 expression and treating cance2023
Approach for treating inflammatory disorders2020
Modified TGF-beta oligonucleotides2020
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2018
Modified TGF-beta oligonucleotides2018
Modified TGF-beta2 oligonucleotides2017
Modified TGF-beta oligonucleotide for use in a method of preventing and/or treat2017
Method for selective oligonucleotide modification2015